Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy

A 30‐year‐old male developed a PET‐positive left‐sided cervical lymphadenopathy that was suspected representing metastasis of a known right‐sided papillary thyroid cancer. First‐dose‐application of Spikevax three weeks ago was neither reflected, nor reported to the pathologists. Diagnostic lymphaden...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzankov, Alexandar, Rössle, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891747/
https://www.ncbi.nlm.nih.gov/pubmed/35280088
http://dx.doi.org/10.1002/ccr3.5398
_version_ 1784661965128335360
author Tzankov, Alexandar
Rössle, Matthias
author_facet Tzankov, Alexandar
Rössle, Matthias
author_sort Tzankov, Alexandar
collection PubMed
description A 30‐year‐old male developed a PET‐positive left‐sided cervical lymphadenopathy that was suspected representing metastasis of a known right‐sided papillary thyroid cancer. First‐dose‐application of Spikevax three weeks ago was neither reflected, nor reported to the pathologists. Diagnostic lymphadenectomy was performed showing extrafollicular proliferation of B‐blasts, likely attributable to the vaccine application.
format Online
Article
Text
id pubmed-8891747
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88917472022-03-10 Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy Tzankov, Alexandar Rössle, Matthias Clin Case Rep Clinical Images A 30‐year‐old male developed a PET‐positive left‐sided cervical lymphadenopathy that was suspected representing metastasis of a known right‐sided papillary thyroid cancer. First‐dose‐application of Spikevax three weeks ago was neither reflected, nor reported to the pathologists. Diagnostic lymphadenectomy was performed showing extrafollicular proliferation of B‐blasts, likely attributable to the vaccine application. John Wiley and Sons Inc. 2022-03-02 /pmc/articles/PMC8891747/ /pubmed/35280088 http://dx.doi.org/10.1002/ccr3.5398 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Images
Tzankov, Alexandar
Rössle, Matthias
Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
title Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
title_full Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
title_fullStr Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
title_full_unstemmed Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
title_short Extrafollicular proliferation of B‐blasts: Morphologic correlate to Spikevax‐induced lymphadenopathy
title_sort extrafollicular proliferation of b‐blasts: morphologic correlate to spikevax‐induced lymphadenopathy
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891747/
https://www.ncbi.nlm.nih.gov/pubmed/35280088
http://dx.doi.org/10.1002/ccr3.5398
work_keys_str_mv AT tzankovalexandar extrafollicularproliferationofbblastsmorphologiccorrelatetospikevaxinducedlymphadenopathy
AT rosslematthias extrafollicularproliferationofbblastsmorphologiccorrelatetospikevaxinducedlymphadenopathy

Ejemplares similares